【晶采观察·奋进“十五五”】守护升级！健康中国重塑全民生活新范式

Core Insights - The article highlights the significant improvements in grassroots healthcare services in China, emphasizing the convenience and efficiency experienced by patients [1] - The introduction of the 2025 dual directory for medical insurance and commercial insurance, effective from January 1, 2024, is a key development, featuring a new list of innovative drugs [1] - The inclusion of critical innovative drugs, such as CAR-T therapy for leukemia, in the commercial insurance directory is expected to alleviate the financial burden on patients [1] Group 1 - The grassroots healthcare system has been upgraded, allowing for quick and efficient medical services, with common medications available through insurance [1] - The newly established commercial insurance innovative drug directory includes 19 essential drugs for major diseases, selected by a professional committee [1] - CAR-T therapy, a vital treatment for leukemia, is now included in the commercial insurance directory, significantly reducing patient costs [1] Group 2 - The focus of health services is shifting towards preventive care, aligning with the "14th Five-Year Plan" to promote health awareness among the public [2] - Over 90% of residents can access healthcare services within 15 minutes, enhancing the capability of community hospitals to handle common ailments [2] - Improving public health literacy is crucial for transitioning from a reactive to a proactive health management approach [2]